|James C. Vestal, a Texas urologist, exposed his patients to ''unnecessary risk'' and ''submitted false information in required reports'' during the clinical trial of a prostate cancer drug, according to the US FDA. Vestal continued to conduct drug trials as recently as last year, as he was permitted to do. He has stopped voluntarily while negotiating with the FDA on his case.
Read the rest of the story HERE:
Sheila Samples is an Oklahoma writer and a former civilian US Army Public Information Officer. She is a Managing Editor for OpEd News, and a regular contributor for a variety of Internet sites.
|The views expressed herein are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.